BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33819278)

  • 1. A metric learning method for estimating myelin content based on T2-weighted MRI from a de- and re-myelination model of multiple sclerosis.
    Pridham G; Hossain S; Rawji KS; Zhang Y
    PLoS One; 2021; 16(4):e0249460. PubMed ID: 33819278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing Structural Changes With Devolving Remyelination Following Experimental Demyelination Using High Angular Resolution Diffusion MRI and Texture Analysis.
    Luo T; Oladosu O; Rawji KS; Zhai P; Pridham G; Hossain S; Zhang Y
    J Magn Reson Imaging; 2019 Jun; 49(6):1750-1759. PubMed ID: 30230112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Imaging of Immune Cell Dynamics During De- and Remyelination in the Cuprizone Model of Multiple Sclerosis by [
    Zinnhardt B; Belloy M; Fricke IB; Orije J; Guglielmetti C; Hermann S; Wagner S; Schäfers M; Van der Linden A; Jacobs AH
    Theranostics; 2019; 9(6):1523-1537. PubMed ID: 31037121
    [No Abstract]   [Full Text] [Related]  

  • 4. Application of q-Space Diffusion MRI for the Visualization of White Matter.
    Fujiyoshi K; Hikishima K; Nakahara J; Tsuji O; Hata J; Konomi T; Nagai T; Shibata S; Kaneko S; Iwanami A; Momoshima S; Takahashi S; Jinzaki M; Suzuki N; Toyama Y; Nakamura M; Okano H
    J Neurosci; 2016 Mar; 36(9):2796-808. PubMed ID: 26937016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlating new directional measures of myelin and axonal integrity in T2-weighted MRI with quantitative histology in multiple sclerosis.
    Sharma S; Laule C; Moore GRW; Li DKB; Zhang Y
    J Neurosci Methods; 2019 Jan; 311():369-376. PubMed ID: 30240805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls.
    Yoo Y; Tang LYW; Brosch T; Li DKB; Kolind S; Vavasour I; Rauscher A; MacKay AL; Traboulsee A; Tam RC
    Neuroimage Clin; 2018; 17():169-178. PubMed ID: 29071211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis.
    Wei W; Poirion E; Bodini B; Tonietto M; Durrleman S; Colliot O; Stankoff B; Ayache N
    Neuroimage; 2020 Dec; 223():117308. PubMed ID: 32889117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis?
    Zivadinov R
    Neurology; 2007 May; 68(22 Suppl 3):S72-82; discussion S91-6. PubMed ID: 17548573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. q-Space Myelin Map imaging for longitudinal analysis of demyelination and remyelination in multiple sclerosis patients treated with fingolimod: A preliminary study.
    Tanikawa M; Nakahara J; Hata J; Suzuki S; Fujiyoshi K; Fujiwara H; Momoshima S; Jinzaki M; Nakamura M; Okano H; Takahashi S; Suzuki N
    J Neurol Sci; 2017 Feb; 373():352-357. PubMed ID: 28088313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis.
    de Paula Faria D; Real CC; Estessi de Souza L; Teles Garcez A; Navarro Marques FL; Buchpiguel CA
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited One-time Sampling Irregularity Map (LOTS-IM) for Automatic Unsupervised Assessment of White Matter Hyperintensities and Multiple Sclerosis Lesions in Structural Brain Magnetic Resonance Images.
    Rachmadi MF; Valdés-Hernández MDC; Li H; Guerrero R; Meijboom R; Wiseman S; Waldman A; Zhang J; Rueckert D; Wardlaw J; Komura T
    Comput Med Imaging Graph; 2020 Jan; 79():101685. PubMed ID: 31846826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
    Zhang Y; Jonkman L; Klauser A; Barkhof F; Yong VW; Metz LM; Geurts JJ
    Mult Scler; 2016 Oct; 22(12):1569-1577. PubMed ID: 26754802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of Myelin for the Diagnosis and Treatment Monitoring of Multiple Sclerosis.
    Nakahara J
    Adv Exp Med Biol; 2019; 1190():249-256. PubMed ID: 31760648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination.
    Huitema MJD; Strijbis EMM; Luchicchi A; Bol JGJM; Plemel JR; Geurts JJG; Schenk GJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of Rapid Magnetic Resonance Myelin Imaging in Multiple Sclerosis.
    Ouellette R; Mangeat G; Polyak I; Warntjes M; Forslin Y; Bergendal Å; Plattén M; Uppman M; Treaba CA; Cohen-Adad J; Piehl F; Kristoffersen Wiberg M; Fredrikson S; Mainero C; Granberg T
    Ann Neurol; 2020 May; 87(5):710-724. PubMed ID: 32057118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T1-/T2-weighted ratio differs in demyelinated cortex in multiple sclerosis.
    Nakamura K; Chen JT; Ontaneda D; Fox RJ; Trapp BD
    Ann Neurol; 2017 Oct; 82(4):635-639. PubMed ID: 28833377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging of demyelination and remyelination models.
    Pirko I; Johnson AJ
    Curr Top Microbiol Immunol; 2008; 318():241-66. PubMed ID: 18219821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
    Mohan H; Friese A; Albrecht S; Krumbholz M; Elliott CL; Arthur A; Menon R; Farina C; Junker A; Stadelmann C; Barnett SC; Huitinga I; Wekerle H; Hohlfeld R; Lassmann H; Kuhlmann T; Linington C; Meinl E
    Acta Neuropathol Commun; 2014 Dec; 2():168. PubMed ID: 25589163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelination- and immune-mediated MR-based brain network correlates.
    Cerina M; Muthuraman M; Gallus M; Koirala N; Dik A; Wachsmuth L; Hundehege P; Schiffler P; Tenberge JG; Fleischer V; Gonzalez-Escamilla G; Narayanan V; Krämer J; Faber C; Budde T; Groppa S; Meuth SG
    J Neuroinflammation; 2020 Jun; 17(1):186. PubMed ID: 32532336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.